Gilotrif is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Afatinib.
| Product ID | 0597-0138_256c019d-6658-43f0-8ec5-2dee75f0e92d |
| NDC | 0597-0138 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Gilotrif |
| Generic Name | Afatinib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-07-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA201292 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | AFATINIB |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2013-08-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA201292 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-08-08 |
| Marketing Category | NDA |
| Application Number | NDA201292 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-08-08 |
| Ingredient | Strength |
|---|---|
| AFATINIB | 40 mg/1 |
| SPL SET ID: | fd638e5e-8032-e7ca-0179-95e96ab5d387 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0137 | Gilotrif | afatinib |
| 0597-0138 | Gilotrif | afatinib |
| 0597-0141 | Gilotrif | afatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GILOTRIF 86011486 4470944 Live/Registered |
Boehringer Ingelheim International GmbH 2013-07-16 |